| Trial Identifier: | D0816C00025 |
| Sponsor: | AstraZeneca |
| Start Date: | January 2020 |
| Primary Completion Date: | February 2025 |
| Study Completion Date: | February 2025 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| DE | Heidelberg, DE, 69120 |
| DK | København Ø, DK, 2100 |
| ES | Madrid, ES, 28009 |
| FR | Lille, FR, 59000 |
| FR | Toulouse, FR, 31300 |
| FR | Villejuif Cedex, FR, 94805 |
| GB | Glasgow, GB, G51 4TF |
| GB | Sutton, GB, SM2 5PT |
| KR | Seoul, KR, 03080 |
| KR | Seoul, KR, 05505 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company